HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: vir.0.008771-0v1 90/5/1153    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Muller, W. J. Articles by Koelle, D. M. Search for Related Content PubMed PubMed Citation Articles by Muller, W. J. Articles by Koelle, D. M. Agricola Articles by Muller, W. J. Articles by Koelle, D. M.

Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection

William J. Muller^1,

David Kaslow^3,

¹ Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle, WA, USA
² Department of Medicine, University of Washington, Seattle, WA, USA
³ Vical Inc., San Diego, CA, USA
⁴ Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
⁵ Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA
⁶ Department of Global Health Medicine, University of Washington, Seattle, WA, USA
⁷ Fred Hutchinson Cancer Research Center, Seattle, WA, USA
⁸ Benaroya Research Institute, Seattle, WA, USA

Correspondence
William J. Muller
wjmuller{at}northwestern.edu

Cytotoxic T cells are important in controlling herpes simplex virus type 2 (HSV-2) reactivation and peripheral lesion resolution. Humans latently infected with HSV-2 have cytotoxic T cells directed against epitopes present in tegument proteins. Studies in mice of immunity to HSV have commonly focused on immunodominant responses in HSV envelope glycoproteins. These antigens have not proved to be an effective prophylactic vaccine target for most of the human population. The murine immune response against HSV tegument proteins has not been explored. We analysed cellular responses in BALB/c mice directed against the tegument proteins encoded by UL46, UL47 and UL49 and against the envelope glycoprotein gD after DNA vaccination or HSV-2 infection. After DNA vaccination, the splenocyte T-cell response to overlapping peptides from UL46 and UL47 was more than 500 gamma interferon spot-forming units per 10⁶ responder cells. Peptide truncation studies, responder cell fractionation and major histocompatibility complex binding studies identified several CD8⁺ and CD4⁺ epitopes. Cellular responses to tegument protein epitopes were also detected after HSV-2 infection. Tegument proteins are rational candidates for further HSV-2 vaccine research.

Present address: Department of Pediatrics, Division of Infectious Diseases, Children's Memorial Hospital, Chicago, IL, USA.

Present address: Merck & Co., Whitehouse Station, NJ, USA.

GenBank/EMBL/DDBJ accession numbers for HSV-2 gene sequences are EU029137–EU029158, EU035980, EU281624–EU281626 and AY779750–AY779754.